Date : 19 June 2026

| Ecosystem Segment | Description | Key Participants |
| Technology Providers | Develop sensing technologies, biosensors, transmitters, mobile connectivity, cloud analytics, and AI-enabled glucose monitoring solutions | Abbott, Dexcom, Medtronic, Senseonics, Nemaura Medical |
| Product Manufacturers | Design and manufacture CGM sensors, transmitters, receivers, and integrated diabetes management systems | Abbott, Dexcom, Medtronic, Roche Diagnostics, Senseonics |
| Digital Health & Platform Providers | Offer CGM-enabled metabolic health programs, coaching platforms, data analytics, and remote monitoring services | Ultrahuman, HealthifyMe, Sugar.fit, BeatO, Ambrosia Systems |
| Software & Analytics Vendors | Provide cloud-based glucose analytics, reporting dashboards, patient engagement tools, and clinician decision-support platforms | Dexcom Clarity, LibreView (Abbott), Medtronic CareLink, Ambrosia Systems |
| Distribution & Commercialization Partners | Handle market access, physician engagement, sales, regulatory compliance, and channel distribution in India | Abbott India, Medtronic India, Roche Diabetes Care India, Ascensia Diabetes Care |
| Healthcare Service Providers | Utilize CGM devices for diabetes diagnosis, treatment optimization, and patient monitoring | Hospitals, Endocrinology Clinics, Diabetes Centers, Telehealth Providers |
| Research & Clinical Institutions | Conduct CGM clinical studies, diabetes research, validation studies, and digital health evaluations | Indian Council of Medical Research, All India Institute of Medical Sciences, Madras Diabetes Research Foundation |
| End Users | Individuals and organizations using CGM systems for diabetes and metabolic health management | Type 1 Diabetes Patients, Type 2 Diabetes Patients, Prediabetic Individuals, Healthcare Providers, Corporate Wellness Programs |
| Regulatory & Standards Bodies | Oversee device approvals, quality standards, and market access | Central Drugs Standard Control Organization, Bureau of Indian Standards |
R&D
Clinical Trials and Regulatory Approvals
Patient Support and Services
| Tier 1 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to CGM |
| Abbott Laboratories | Abbott Park, Illinois | USA | Clear market leader in India CGM market with extensive physician adoption, strong distribution network, and significant penetration through Libre systems | FreeStyle Libre, FreeStyle Libre 2, LibreView |
| Dexcom | San Diego, California | USA | Global leader in real-time CGM technology with growing adoption among insulin-dependent diabetes patients and digital health users in India | Dexcom G7, Dexcom ONE+, Dexcom Clarity |
| Medtronic plc | Galway | Ireland | Major player in advanced diabetes management with integrated CGM and automated insulin delivery systems | Guardian 4 Sensor, MiniMed 780G System |
| Roche Diagnostics | Rotkreuz, Zug | Switzerland | Established diabetes monitoring company leveraging its diabetes care ecosystem and physician relationships to expand CGM offerings | Accu-Chek Smart CGM Solutions, Digital Diabetes Platforms |
| Ascensia Diabetes Care | Basel | Switzerland | Commercialization partner for implantable CGM technologies and an established diabetes management company with expanding CGM presence | Eversense CGM (via Senseonics partnership), Diabetes Management Solutions |
| Tier 2 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| Senseonics Holdings | Germantown, Maryland | USA | Pioneer in long-duration implantable CGM systems | Eversense CGM |
| Ultrahuman Healthcare Pvt. Ltd. | Bengaluru, Karnataka | India | Major metabolic health platform utilizing CGM technology | Ultrahuman M1 |
| HealthifyMe Wellness Pvt. Ltd. | Bengaluru, Karnataka | India | Integrates CGM into digital metabolic health programs | Healthify CGM Programs |
| Sugar.fit | Bengaluru, Karnataka | India | Large diabetes care platform using CGM-based coaching | CGM-enabled Diabetes Reversal Programs |
| BeatO (Health Arx Technologies) | New Delhi, Delhi | India | Expanding CGM-supported diabetes management ecosystem | BeatO CGM Services |
| Tier 3 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| DrStore Healthcare Services India Pvt. Ltd. (Tracky) | Gurugram, Haryana | India | Launched India's Bluetooth-enabled CGM offering | Tracky CGM |
| Actofit Tech Pvt. Ltd. | Mumbai, Maharashtra | India | Expanding preventive-health CGM applications | Actofit CGM Programs |
| Nemaura Medical, Inc. | Loughborough | United Kingdom | Developer of non-invasive glucose monitoring technologies | SugarBEAT |
| GlucoRx Ltd. | Surrey, England | United Kingdom | Technology provider supporting newer CGM solutions entering India | GlucoRx CGM Systems |
| Ambrosia Systems Inc. | San Jose, California | USA | Provides CGM analytics and monitoring services increasingly used in India | NightRider, CGM Analytics |
The India continuous glucose monitoring devices market size stood at US$ 165 million in 2025, grew to US$ 189.42 million in 2026, and is forecast to reach US$ 656 million by 2035, expanding at a CAGR of 14.8% from 2026 to 2035.

Speak with a healthcare analyst about your research, consulting, or platform needs.